Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-18-003117
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-10 16:39:29
Reporting Period:
2018-01-09
Accepted Time:
2018-01-10 16:39:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
57725 Lannett Co Inc LCI Pharmaceutical Preparations (2834) 230787699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1262311 David Farber 13200 Townsend Road
Philadelphia PA 19154
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-09 10,000 $25.01 4,171,269 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Farber on November 22, 2017. The 10b5-1 trading plan will allow Mr. Farber to diversify a portion of his holdings consistent with SEC Rule 10b5-1 and the Company's Insider Trading Policy.